Prolonged ovalbumin challenge facilitates Th17 polarization in sensitized mice

Inflammation Research

Volumn 59, Issue 7, 2010, Pages 561-569

  Wang, Qing ^a   Li, Hequan ^a   Zhang, Zhiyuan ^a   Yao, Yinan ^a   Zhou, Jianying ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

IL 17; Ovalbumin; ROR t; Th17

Indexed keywords

INTERLEUKIN 23; INTERLEUKIN 6; OVALBUMIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATORY CELL; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; TH17 CELL; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; HELPER CELL; IMMUNOLOGY; LUNG; LUNG LAVAGE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CELL DIFFERENTIATION; CELL POLARITY; CYTOKINES; INTERLEUKIN-23; INTERLEUKIN-6; LUNG; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; OVALBUMIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFORMING GROWTH FACTOR BETA;

EID: 77955716091     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0162-z     Document Type: Article

References (42)

1. Lloyd CM, Gonzalo J, Nguyen T, Delaney T, Tian J, Oettgen H, et al. Resolution of bronchial hyperresponsiveness and pulmonary inflammation is associated with IL-3 and tissue leukocyte apoptosis. J Immunol. 2000;166:2033-40.
2. McMillan SJ, Xanthou G, Lloyd CM. Therapeutic administration of budesonide ameliorates allergen-induced airway remodelling. Clin Exp Allergy. 2005;35:388-96.
3. Janssen EM, van Oosterhout AJ, Nijkamp FP, van Eden W, Wauben MH. The efficacy of immunotherapy in an experimental murine model of allergic asthma is related to the strength and site of T cell activation during immunotherapy. J Immunol. 2000;165:7207-14.
4. Lloyd CM, McMillan SJ. Prolonged allergen challenge in mice leads to persistent airway remodeling. Clin Exp Allergy. 2004;34:497-507.
5. Palmans E, Kips CJ, Pauwels RA. Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med. 2000;161:627-35.
6. Koerner-Rettberg C, Doths S, Stroet A, Schwarze J. Reduced lung function in a chronic asthma model is associated with prolonged inflammation, but independent of peribronchial fibrosis. PLoS One. 2008;6:e1575.
7. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax. 1998;53:849-56.
8. Jain VV, Kitagaki K, Businga T, Hussain I, George C, O'Shaughnessy P, et al. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J Allergy Clin Immunol. 2002;110:867-72.
9. Swirski FK, Sajic D, Robbins DS, Gajewska BU, Jordana M, Stampfli MR. Chronic exposure to innocuous antigen in sensitized mice leads to suppressed airway eosinophilia that is reversed by granulocyte macrophage colony-stimulating factor. J Immunol. 2002;169:3499-506.
10. Sakai K, Yokoyama A, Kohno N, Hamada H, Hiwada K. Prolonged antigen exposure ameliorates airway inflammation but not remodeling in a mouse model of bronchial asthma. Int Arch Allergy Immunol. 2001;126:126-34.
11. Cui ZH, Skoogh BE, Pullerits T, Lotvall J. Bronchial hyperresponsiveness and airway wall remodelling induced by exposure to allergen for 9 weeks. Allergy. 1999;54:1074-82.
12. Van Hove CL, Maes T, Joos GF, Tournoy KG. Prolonged inhaled allergen exposure can induce persistent tolerance. Am J Respir Cell Mol Biol. 2007;36:573-84.
13. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-8.
14. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006;441:231-4.
15. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17 ? T Helper cells. Cell. 2006;126:1121-33.
16. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-32.
17. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233-40.
18. Quyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008;28:454-67.
19. Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res. 2006;7:135.
20. Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, Overbergh L, et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol. 2003;28:42-50.
21. Sergejeva S, Ivanov S, Lotvall J, Linden A. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am J Respir Cell Mol Biol. 2005;33:248-53.
22. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity. 2004;21:467-76.
23. Martinez GJ, Nurieva RI, Yang XO, Dong C. Regulation and function of proinflammatory TH17 cells. Ann NY Acad Sci. 2008;1143:188-211.
24. Lee SY, Kim JS, Lee JM, Kwon SS, Kim KH, Moon HS, et al. Inhaled corticosteroid prevents the thickening of airway smooth muscle in murine model of chronic asthma. Pulm Pharmacol Ther. 2008;21:14-9.
25. Melgern BN, Timens W, Kerstjens HA, Geerlings M, Luing MA, Schouten JP, et al. Effects of 4 months of smoking in mice with ovalbumin-induced airway inflammation. Clin Exp Allergy. 2007;37:1798-808.
26. Li H, Xie Q, Wang H, Shao C, Chen W. Intramuscular delivery of mIL-12 gene reduces the expression of CD44/CD49d on pulmonary leucocytes and inhibits ovalbumin-induced airway hyperreactivity. Inflamm Res. 2008;57:11-7.
27. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 1996;183:195-201.
28. McMillan SJ, Xanthou G, Lloyd CM. Manipulation of allergeninduced airway remodeling by treatment with anti-TGF-beta antibody: effect on the smad signaling pathway. J Immunol. 2005;174:5774-80.
29. Shiraishi Y, Asano K, Nakajima T, Oguma T, Suzuki Y, Shiomi T, et al. Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J Pharmacol Exp Ther. 2005;312:954-60.
30. + CD25? Foxp3? T cells independent of interleukin-10. Infect Immun. 2009;77:98-107.
31. Krishnan S, Warke VG, Nambiar MP, Wong HK, Tsokos GC, Farber DL. Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3zeta expression. Blood. 2001;97:3851-9.
32. Moisan J, Grenningloh R, Bettelli E, Oukka M, Ho IC. Ets-1 is a negative regulator of Th17 differentiation. J Exp Med. 2007;204:2825-35.
33. Overbergh L, Valckx D, Waer M, Mathieu C. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine. 1999;11:305-12.
34. Tourdot S, Mathie S, Hussell T, Edwards L, Wang H, Openshaw PJ, et al. Respiratory syncytial virus infection provokes airway remodeling in allergen-exposed in absence of prior allergen sensitization. Clin Exp Allergy. 2008;38:1016-24.
35. He R, Oyoshi MK, Jin H, Geha RS. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc Natl Acad Sci USA. 2007;104:15817-22.
36. Zhang Z, Zhong W, Spencer D, Chen H, Lu H, Kawaguchi T, et al. Interleukin-17 causes neutrophil mediated inflammation in ovalbumin-induced uveitis in DO11.10 mice. Cytokine. 2009;46:79-91.
37. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003;278:1910-4.
38. Eberl G, Littman DR. The role of the nuclear hormone receptor RORgammat in the development of lymph nodes and Peyer's patches. Immunol Rev. 2003;195:81-90.
39. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity. 2008;28:29-39.
40. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998;282:2258-61.
41. Hamelmann E, Cieslewicz G, Schwarze J, Ishizuka T, Joetham A, Heusser C, et al. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness. Am J Respir Crit Care Med. 1999;160:934-41.
42. Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, Quesniaux V, et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med. 2006;27:2715-25.